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ABSTRACT PAGE
Previous studies have shown that muscarinic receptor blockade decreases signal detection 
in a sustained attention task that requires discrimination of visual signals from trials with no 
signal presentation. However, the exact role of specific muscarinic receptor subtypes in 
attentional performance remains unclear. The present experiments examined the effects of 
blocking M1 receptors on attentional performance in rats. Rats were trained in a two-lever 
sustained attention task that required discrimination of visual signals (500, 100, 25 ms) from 
“blank” trials when no signal was presented. In Experiment 1, rats received the M1 receptor 
antagonist, dicyclomine (0, 0.625, 1.25, 2.5, and 5.0 mg/kg; ip), prior to performance in this 
task and prior to performing the task with a houselight flashing throughout the session or 
with a shorter intertrial interval. Dicyclomine (5.0 mg/kg) decreased the detection of signals 
in the standard task when compared to vehicle. Similarly, accuracy was decreased following 
5.0 mg/kg dicyclomine compared to vehicle with a shorter intertrial interval, however, the 
deficit was only observed following the 100 ms signal. In the distracter task, when vehicle 
was compared to drug treatment, animals exhibited significant signal detection deficits at 
lower doses compared to the standard task. In Experiment 2, a guide cannula was surgically 
implanted into either the right or left ventricle of rats after reaching stable performance 
levels. All animals received infusions of the M1 receptor antagonist, pirenzepine (0, 10, 30, 
and 60 pg) prior to performing the standard attention task. Pirenzepine decreased accuracy 
of detecting the 500 ms signal following the highest dose (60 pg) when compared to vehicle. 
The lack of effects of dicyclomine and pirenzepine on trials with no signal presentation or on 
omissions suggests that M1 receptor blockade does not disrupt motoric functioning, 
motivation or the ability to respond based upon the rules of the task. The present results 
suggest that M1 receptors critically contribute to attentional processing mediated by the 
central cholinergic system.
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1Blockade of muscarinic M l receptors disrupts performance in an attention- 
demanding visual discrimination task 
Attention has been described as the ability to detect and select stimuli for 
further processing (Knudsen, 2007). Attention is carried out by a network of 
anatomical areas, as opposed to a single brain region or a general function of the 
brain operating as a whole (Posner & Peterson, 1990). Neurological models of 
attention have differentiated separate subcomponents of attention, such as 
sustained attention and selective attention, which can be defined functionally and 
to some extent, anatomically. Vigilance or sustained attention concerns the ability 
of observers to maintain attention and remain alert to stimuli over prolonged 
periods of time (Parasuraman, Warm, & Dember, 1987). Being able to sustain 
attention is a critical behavioral adaptation because it is a basic requirement for 
the acquisition and recall o f information (Sarter, Bruno, & Givens, 2003). The 
attentional system warrants further investigation because disruptions in this 
system could impair learning and memory, possibly contributing to deficits in 
some neuropsychiatric diseases including Alzheimer’s disease.
Attentional deficits in Alzheimer’s disease
Deficits in attention have been associated with the early stages of 
Alzheimer's disease (AD) (Perry & Hodges, 1999). Cholinergic neuron loss is 
thought to underlie the cognitive impairments seen in AD and provides the 
rationale for cholinergic replacement pharmacotherapies (Bartus, Dean, Beer, & 
Lippa, 1982). Based on the cholinergic hypothesis, acetylcholinesterase inhibitors
2(AChE-Is) have emerged as the main therapeutic agents in treating AD. The 
AChE-Is act on the acetylcholine (ACh) pathway by inhibiting the enzyme 
acetylcholinesterase, which is normally responsible for hydrolysis of ACh. AChE- 
Is have been found to improve, or at least slow deterioration for some aspects of 
cognitive performance in patients with AD (Rogers, Farlow, Doody, Mohs, & 
Friedhoff, 1998). Systemic drug administration o f an ACh-I, donepezil, has been 
found to enhance cognitive function (Rogers et al., 1998) including attentional 
performance (Salloway et al., 2004) in patients with mild to moderate AD.
Several long-term clinical trials with AChE-Is have reported that these drugs 
actually decrease the rate of cognitive decline, and may delay the disease 
progression by 1 to 2 years (Farlow, 2002) but the benefits are modest (Courtney 
et al., 2004). AChE-Is are unable to slow progression from mild cognitive 
impairment to dementia (Raschetti, Albanese, Vanacore, & Maggini, 2007).
While AChE-Is are the best current option for the treatment of AD, a drug that is 
more selective to the particular cholinergic receptors affected by the disease may 
be better at treating the symptoms and slowing the progression of the disease. 
AChE-Is act to increase the level and duration of ACh in the synapse so ACh can 
bind to all cholinergic receptors. A better understanding of the cholinergic 
receptors involved in attention may allow the development o f more targeted drugs 
to provide maximal attention-related benefits via the cholinergic system.
There is evidence to support the hypothesis that cognitive disturbances 
associated with AD are due to disruptions in the cholinergic system (Auld,
3Komecook, Bastianetto, & Quirion, 2002). Neurons of the basal forebrain 
undergo a profound and selective degeneration in AD patients which leads to a 
cholinergic deficiency in their brains (Bartus et al., 1982; Whitehouse et al., 1982). 
While the behavioral effects of ACh on the brain have been extensively 
characterized by administering cholinergic drugs to human subjects, animal 
experiments have provided further insight into the function of the cholinergic 
system through controlled experiments. However, the assessment o f attention in 
animals needs to be carefully considered before applying manipulations o f brain 
function.
Measuring attention in the rat
A taxonomy for sustained attention has been developed to understand the 
different task parameters that can affect performance (Parasuraman et al., 1987). 
According to this taxonomy, one factor that contributes to sustained attention- 
demanding tasks is the event rate. Events that are presented quickly or at a 
variable rate have been shown to disrupt performance in tests of sustained 
attention (Parasuraman et al., 1987). Another important dimension that places 
demands on sustained attention is whether signals and nonsignals are presented 
successively (successive discrimination) from a single location. Successive 
discrimination places additional demands on the animal because signals have to 
be distinguished from a nonsignal reference represented in recent memory 
(Parasuraman et al., 1987). The use of dynamic stimuli, such as signals with 
variable duration also increases attentional load because they are more difficult to
4discriminate (McGaughy & Sarter, 1995). Taking these factors into consideration, 
McGaughy and Sarter (1995) modified a task by Bushnell, Kelly, and Crofton 
(1994) to develop an attention-demanding two-lever task that required rats to 
discriminate between successively presented signals and nonsignals. The task 
includes several features (competing response rules, variable signal duration, and 
variable intertrial interval (ITI)) that impose a cognitive load, ensuring that even 
the basic version of the task cannot be successfully completed on the basis of side 
biases or simple response timing. The task instead requires directed attention to 
the presence or absence of brief visual stimuli on each trial. Distraction (in the 
form of a flashing houselight) (Gill, Sarter, & Givens, 2000; Himmelheber, Sarter, 
& Bruno, 2000) and decreasing the time between signal and nonsignal events 
(short ITI) (McGaughy & Sarter, 1995) can be introduced to challenge 
performance and increase attentional demands. The development of this task has 
allowed for more in depth research o f attention because it improves upon previous 
tasks that did not provide a valid measure of the subjects’ ability to discriminate 
between signal and nonsignal events. In previous tasks, baseline lever pressing 
rates could confound the false alarm rate (McGaughy & Sarter, 1995).
Specifically, previous tasks had a lever extended throughout the session and 
animals were trained to press the lever after a stimulus (e.g., a brief light) was 
presented. Lever presses in the absence of the light were considered false alarms. 
However, any manipulation (e.g, drug treatment) that influences baseline lever 
pressing rate would be expected to impact the false alarm rate. Thus, it was
5difficult to establish whether changes in the false alarm rate reflected changes in 
signal processing or the baseline lever pressing rate. The modified task prevents 
spontaneous lever pressing because the levers are only extended after a signal or 
nonsignal event and are retracted during the ITI.
Basal forebrain cholinergic system
The basal forebrain is a collection of structures that lie near the bottom of 
the anterior portion of the brain, ventrally to the striatum that includes the nucleus 
basalis of Meynert, diagonal band of Broca, and medial septal nuclei (Mesulam, 
Mufson, Wainer, & Levey, 1983). Collectively, from these structures within the 
basal forebrain, cholinergic neurons send projections widely throughout the brain, 
including to the amygdala, thalamus, cortical mantle, hippocampal formation, and 
the olfactory bulb (Mesulam et al., 1983).
Experiments that have selectively damaged the basal forebrain have been 
used for elucidating the function of this structure, particularly with regard to 
cognitive processing. Excitotoxic lesions of the basal forebrain have been shown 
to decrease accuracy on a five-choice serial reaction time task which is designed 
to assess multiple aspects of cognition, such as sustained attention and impulsivity 
(Muir, Everit, & Robbins, 1994). Tasks that place explicit demands on attentional 
processes rather than learning and memory appear particularly sensitive to lesions 
of the basal forebrain (Voykto et al., 1994). The development o f a selective 
cholinergic immunotoxin, 192 IgG-saporin, has provided further support for the 
role o f the basal forebrain corticopetal cholinergic neurons in attention
6(McGaughy, Everitt, Robbins, & Sarter, 2000). 192 IgG is an antibody to the rat 
p75 nerve growth receptor. This antibody can be coupled to saporin, a ribosome- 
inactivating protein that causes cell death (Wiley, Oeltmann, & Lappi, 1991). 192 
IgG-saporin, specifically targets and destroys cortically-projecting cholinergic 
neurons of the basal forebrain, the only neurons in the basal forebrain that express 
the p75 nerve growth factor receptor (Wiley et al., 1991). McGaughy, Kaiser, & 
Sarter (1996) found that intrabasalis infusions of 192 IgG-saporin decrease signal 
detection in a sustained attention task. In a separate experiment employing a five- 
choice serial reaction time task, intrabasalis infusions of high or low doses of 192 
IgG-saporin produced different degrees of damage that correlated with the degree 
o f accuracy deficit (McGaughy, Dailey, Morrison, Everitt, & Robbins, 2002). 
Furthermore, the accuracy deficit was significantly correlated with a reduction in 
cortical ACh efflux in rats with extensive lesions only.
Although cortical cholinergic inputs are critical for maintaining attentional 
performance they are of particular importance under conditions of increased 
attentional demands. Burk, Lowder, and Altemose (2008) found that loss of basal 
forebrain corticopetal cholinergic neurons can decrease signal detection in a 
sustained attention task, but only under conditions when multiple aspects of the 
task are attention-demanding. Animals were initially trained with minimal 
attentional demands and then following loss of cortical cholinergic inputs the task 
parameters were altered to increase attentional demands. No single task 
parameter disrupted signal detection following loss of basal forebrain corticopetal
7cholinergic neurons, but signal detection was disrupted under conditions when 
multiple aspects of the task were attention-demanding. Thus, cortical ACh is 
critical for attentional effort or the recruitment of attentional mechanisms in 
response to challenges (Sarter, Gehring, & Kozak, 2006).
Cortical ACh and attention
Cortical ACh release is more highly elevated in rats performing a 
sustained attention task compared with control tasks (Arnold, Burk, Hodgson, 
Sarter, & Bruno, 2002; Passetti, Dailey, O'Connell, Everitt, & Robbins, 2000). 
Studies assessing cortical ACh release in attentional task-performing rats have 
generated preliminary evidence suggesting that increased demands on sustained 
attention performance are associated with increases in cortical ACh efflux 
(Himmelheber et al., 2000). ACh efflux in the frontoparietal cortex was studied 
with in vivo microdialysis while rats performed in an operant task designed to 
assess sustained attention (Himmelheber et al., 2000). A visual distracter was 
used during task performance to increase attentional demands. When animals 
performed under increased attentional demands there was an increase in cortical 
ACh efflux. The authors speculate that the effects of the distracter on 
performance and cortical ACh efflux were due to its ability to increase 
background noise and disrupt active attentional processing. This finding extends 
hypotheses regarding the crucial role of cortical cholinergic transmission for 
attentional functions. The effects of the distracter stimulus provide evidence for a 
direct relationship between attentional effort and cortical ACh release.
8Recent evidence from studies employing choline-sensitive biosensors 
suggest that ACh regulates attentional processing on multiple time scales, 
involving a tonic component that relates more to arousal and a phasic component 
that appears to contribute more to cue detection (Parikh, Kozak, Martinez, & 
Sarter, 2007). These studies support the general hypothesis that cortical 
cholinergic inputs, while not exclusively mediating attentional processes, are 
likely to be activated by behavioral situations taxing attentional capabilities. 
Muscarinic receptors
ACh binds to both muscarinic and nicotinic cholinergic receptors (Cooper, 
Bloom, & Roth, 2003). The blockade of muscarinic receptors, but not nicotinic 
receptors, disrupts attentional performance in monkeys (Herrero et al,, 2008) and 
in rats (Johnson & Burk, 2006; McQuail & Burk, 2006). Muscarinic receptors 
belong to a class o f metabotropic receptors which use G proteins as their signaling 
mechanism (Cooper, et al., 2003). Muscarinic acetylcholine receptors are 
involved in memory and attention (Broks et al., 1988), and it is hypothesized that 
a muscarinic agonist could provide a replacement therapy in AD. However, the 
exact role of specific muscarinic receptor subtypes in attentional performance 
remains unclear. Five different muscarinic receptor subtypes (M1-M5) have been 
identified. In terms of a role in cognitive processing, most research has assessed 
the contributions o f M l and M2 receptors. M l receptors are primarily post- 
synaptic receptors and M2 receptors are pre-synaptic autoreceptors, which act to 
negatively modulate acetylcholine release (Clader & Wang, 2005). Muscarinic
9receptor blockade produces cognitive impairments (McQuail & Burk, 2006), and 
it is thought that these effects most likely involve M l receptors because M2 
receptor blockade would be expected to increase acetylcholine release. M2 
receptors have also been shown to decline in AD brains while M l receptor levels 
remained unchanged (Flynn, Ferrari-DiLeo, Levey, & Marsh, 1995). With 
decreasing levels of M2 receptors there may not be adequate neural substrate for 
M2 receptor antagonists to act upon for treating age- and dementia-related 
cognitive decline. Because M l receptors are retained it makes the M l receptor an 
attractive target for symptomatic treatment of AD. This approach is further 
supported by muscarinic M l receptor agonists that have improved performance 
on cognitive tests in Alzheimer’s patients (Bodick, et al., 1997) and cognition in 
animal models of the disease (Fisher, Brandeis, Chapman, Pittel, & Michaelson, 
1998; Genis, Fisher, & Michaelson, 1999). Furthermore, impairment of M l 
mediated signaling may underlie the cognitive decline of AD via effects on 
protein kinase C activity and NMDA receptor density (Tsang et al., 2007).
Muscarinic M l receptor agonists have been shown to enhance learning 
and memory in animals. The muscarinic M l receptor agonists, arecholine, 
pilocarpine, and McN-A-343, facilitated learning acquisition in an active- 
avoidance paradigm in rats which records an anticipatory conditioned avoidance 
apart from the classical conditioned avoidance response (Sen & Bhatacharya, 
1991). This learning enhancement was later attenuated by the selective Ml 
antagonist, pirenzepine. In addition, M l receptor agonists have been found to
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significantly reduce age-related cognitive impairments (Brandeis, Dachir, Sapir, 
Levy, & Fisher, 1990). Memory functions were impaired in the Morris Water 
Maze and 8-arm radial arm maze in aged rats compared to young animals. The 
administration of AF102B, an M l receptor agonist, significantly reduced the age- 
related cognitive impairments observed in both tasks. The ability of muscarinic 
M l receptor agonists to enhance performance in these memory tasks may result 
from improved attention capacity that can aid in the acquisition of spatial 
navigation strategies (Aura, Sirvio, & Riekkinen Jr., 1997). These data support 
the hypothesis that enhancement of cholinergic function may reverse geriatric 
cognitive deficits.
Not surprisingly, M l receptor antagonists have been found to disrupt 
cognitive performance. Pirenzepine, an M l receptor antagonist, disrupted spatial 
memory (Bymaster, Heath, Hendrix & Shannon, 1993), as well as performance 
accuracy on a delayed non-matching to position task (Aura et al., 1997). Mice 
with a mutation of the gene coding for the Ml receptor showed impaired working 
memory on the radial arm maze as well as impaired acquisition and consolidation 
of contextual fear conditioning (Anagnostaras et al., 2003). This finding suggests 
that the M l receptor is specifically involved in memory processes for which the 
cortex and hippocampus interact. Collectively, these data support the idea that the 
M l receptor is critical in cognitive processing.
Despite the evidence that muscarinic M l receptors are involved in 
memory, the role of these receptors in attentional functioning has not been
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thoroughly investigated. Although it has been suggested that M l receptors are 
critical for attentional performance there are currently no studies that examine the 
role of the M l receptor in an attention demanding task. The present experiments 
were designed to investigate the hypothesis that muscarinic M l activation is 
necessary for performance in an attentional task. Experiment 1 examined the 
effects of systemic administration of dicyclomine, an M l receptor antagonist, on 
attentional performance in rats. A previously validated attention task designed to 
place high demands on attentional processing (e.g., brief and variable signal 
durations and ITIs) and that required the discrimination of a brief visual signal 
from trials with no signal presentation was used. Furthermore, Experiment 1 
investigated the role of the M l receptor when attentional demands were increased. 
Accuracy on the task has been previously shown to decrease when background 
noise is increased by flashing a houselight as well as when the ITI is decreased 
(McGaughy & Sarter, 1995). M l receptor blockade is hypothesized to 
differentially disrupt performance when attentional demands are increased. In 
Experiment 2 the effects of intracerebroventricular (icv) infusions of pirenzepine 
(Ml receptor antagonist) were investigated in the same sustained attention task 
used in Experiment 1. Different M l receptor antagonists were used in 
Experiment 1 and Experiment 2 in order to test the generalizability o f any effects 
of M l receptor blockade on attentional performance. ICV administration was 
used to create widespread receptor blockade, while avoiding any peripheral 
effects o f systemic administration. Widespread receptor blockade was important
12
because only extensive loss of cortical cholinergic inputs have been found to 
disrupt performance in the standard task (McGaughy et al., 1996; Newman & 
McGaughy, 2008). Administration of pirenzepine was expected to disrupt 
detection of visual signals, but not to affect accuracy on nonsignal trials. The lack 
of effect of dicyclomine and pirenzepine on trials with no signal presentation 
suggests that M l receptor blockade does not disrupt the ability to respond based 
upon the rules of the task, motoric functioning or motivation. This selective 
pattern of results has also been observed after lesions of basal forebrain 
corticopetal cholinergic neurons (McGaughy et al., 1996), so a similar pattern of 
results would suggest that M l receptors critically contribute to attentional 
processing mediated by the central cholinergic system.
Method
Experiment 1 
Subjects
Subjects were nine male Long-Evans rats; weighing 151-175 g at the 
beginning of the experiment (Charles River Laboratories Inc., Wilmington, MA). 
Animals were housed individually in hanging wire cages in a vivarium with a 
14/10 h light/dark cycle (lights on 0600-2000). All behavioral testing occurred 
during the light cycle between 0900 and 1200, for five or six days a week. Rats 
were permitted to feed freely, but were water restricted on testing days, receiving 
water during task performance and for 30 min following testing sessions. On 
days the rats were not tested they were allowed free access to water overnight or
13
for 1 h during the day. The experimental protocol was approved by the 
Institutional Animal Care and Use Committee at the College of William and Mary. 
Apparatus
Rats were trained in one of 12 chambers (Med Associates, Inc., Georgia, 
VT) each enclosed within a sound-attenuating box. One side of the chamber 
contained two retractable levers, a water port with a dipper to deliver water (0.01 
ml) situated between the two levers, and a centrally located panel light located 
above the water port. A houselight was located in the back of the chamber. The 
behavioral testing programs and data collection were managed by a personal 
computer utilizing Med-PC version IV software.
Behavioral training
The houselight remained illuminated throughout all testing sessions. In 
the first stage of training, the levers were extended throughout the session and the 
dipper was raised following each lever press. However, following five 
consecutive presses on a single lever, the other lever had to be pressed to receive 
water access. The rule was included to attempt to prevent a lever bias. After 
reaching a criterion of 120 lever presses per session for three sessions, rats were 
trained to discriminate between signals ( I s  illumination of the panel light) and 
nonsignals (no illumination of the panel light). After a signal or nonsignal, the 
levers were extended into the chamber. The rules for a correct response were 
counterbalanced across animals. For half the animals, following a signal, a press 
on the left lever was considered a “hit” and the rat received water access. A
14
response on the right lever was considered incorrect, scored as a “miss” and the 
rat received no water. After a nonsignal, a press on the right lever was considered 
correct, scored as a “correct rejection” and water was given, while pressing the 
left lever was considered a “false alarm”. After a lever press, levers were 
retracted. Failure to press either lever within 3 s was considered an “omission”. 
Half of the animals were trained based on these rules and the other half trained 
with the reverse rules (e.g., right lever press correct after a signal and left lever 
press correct after a nonsignal). The ITI varied (12+3 s) during training to 
prevent the rats from anticipating the onset o f the next trial. Incorrect responses 
were followed by a correction trial that was identical to the previous trial. Three 
consecutive incorrect responses triggered a forced trial where only the correct 
lever was extended into the chamber for 90 s. When the three consecutive errors 
occurred on signal trials, the panel light remained illuminated for the duration of 
the forced trial. Animals were trained in this task until they reached criterion of 
70% hits and 70% correct rejections for three consecutive sessions. In the next 
level o f training the signal duration was reduced and varied within each session 
(500, 100, or 25 ms). A session consisted of 162 trials with an ITI of 9 + 3 sec. 
The signal duration and ITI were decreased to place higher demands on 
attentional processing (McGaughy & Sarter, 1995). Animals were trained in this 
version of the task to a criterion of 70% hits at the 500 ms and 70% correct 
rejections for three consecutive sessions in order to move to the drug 
administration phase of the experiment.
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Drug administration and behavioral testing
Dicyclomine was dissolved in saline and injected into the intraperitoneal 
cavity in a volume on 1.0 ml/kg. The doses used were 0.625, 1.25, 2.50, 5.0 
mg/kg of dicyclomine. The dicyclomine solution was heated for approximately 5 
min until the solution was visibly dissolved.
Rats each received five sessions with three different task manipulations: 
standard task, short ITI, and distracter task. In the short ITI version of the task, 
the ITI was decreased to 4.5 + 3 sec. In the distracter task, the houselight flashed 
on and off at 1 s intervals for the entire session. The order o f the task 
manipulations and drug administration was randomly assigned to each rat. Rats 
received each drug dose for all three task manipulations, for a total of 15 
injections. After an injection, animals were placed in the testing chamber and the 
program was started. There was a 15 min delay between drug administration and 
testing to allow the drug to take effect (Fomari, Moreira, & Oliveira, 2000). 
Between drug administration days, rats returned to the standard task and were 
required to meet a criterion of 70% hits at the 500 ms signal and 70% correct 
rejections before proceeding to the next drug administration day.
Behavioral measures
The number of hits, misses, correct rejections, false alarms, and omissions 
were recorded for each testing session. Omissions were analyzed separately from 
measures of response accuracy.
16
Statistical analysis
The effects of the drug were analyzed separately for each task 
manipulation. The relative number of hits (percentage of hits divided by 100) was 
analyzed using a repeated-measures analysis of variances (ANOVA) with the 
factors o f signal duration and drug dose. The relative number of correct rejections 
(percentage o f correct rejections divided by 100) was also analyzed using a 
repeated-measures ANOVA. A repeated-measures ANOVA was also used to 
analyze the number of omissions. Data analyses were conducted with SPSS 15.0 
for Windows (SPSS, Chicago, IL). P  values were corrected with the Huynh-Feldt 
procedure. An a  level of 0.05 was used to determine statistical significance. 
Experiment 2 
Subjects
Subjects were ten male Long-Evans rats (Charles River Laboratories Inc., 
Wilmington, MA). Animals were housed identically to those in Experiment 1. 
Rats were also water restricted for the duration o f the experiment, receiving water 
during task performance and for 30 min following testing sessions. The 
experimental protocol was approved by the Institutional Animal Care and Use 
Committee at the College of William and Mary.
Apparatus and behavioral training
Animals were trained in the same chambers using the same procedure 
prior to drug administration as in Experiment 1.
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Surgical procedures
Once animals met a criterion of 70% hits at the 500 ms and 70% correct 
rejections for three consecutive sessions they moved to the surgery phase of the 
experiment. Before surgery animals were anesthetized with an intraperitoneal 
injection of 90.0 mg/kg ketamine and 9.0 mg/kg xylazine. The head of the rat was 
shaved and then placed in a Kopf stereotaxic instrument. An incision was made 
through the skin down the center o f the head to expose the skull. A hole was 
drilled and the cannula (8 mm, 22 gauge) was placed into either the right (50% of 
the rats) or left lateral ventricle at the following co-ordinates: AP = -0.8 mm 
posterior, L = 1.6 mm lateral to bregma and V = -2.5 mm relative to bregma.
Three additional holes were drilled for supporting screws, one anterior to the 
guide cannula and two posterior to the guide cannula. The guide cannula and 
three supporting screws were covered in dental acrylic cement. Animals were 
given acetaminophen (2.7 mg/ml) in their water bottle 24 h before surgery and 3 
days following surgery for pain relief.
Post-surgical drug administration and behavioral training
The animals were allowed one week of free water access after surgery 
before returning to training. After returning to a water-deprivation schedule, rats 
were required to maintain 70% hits and 70% correct rejections for 3 sessions 
before drugs could be administered. All rats received infusions of: 0,10, 30, and 
60 pg pirenzepine, dissolved into saline. Drug administration occurred via an 
internal cannula that extended 1.0 mm below the guide cannula. Polyethylene
18
tubing connected the cannula to a 10 pi Hamilton syringe. The syringe was loaded 
into a microinfusion pump (Pump II, Harvard Apparatus). Solutions were infused 
at a rate o f 1.0 pl/min and the total volume injected was 2.5 pi. The infused 
solution was allowed to diffuse for 1 min before replacing the infusion cannula 
with dummy cannula to prevent clogging. There was a 10 min delay between 
drug administration and testing to allow the drug to take effect (Aura et al., 1997). 
Histology
Following completion o f the drug schedule, rats were anesthetized and 
intracardially perfused at 300 mm Hg with 10% sucrose followed by 10% 
formalin. Perfused brains were left overnight in formalin prior to being placed in 
30% sucrose phosphate buffer for approximately three days. The brains were 
frozen and sectioned in the coronal plane with a microtome (50 pm). The brain 
sections were mounted on gelatin-coated slides and dried overnight before being 
stained with cresyl violet and cover-slipped. The sections were then examined to 
determine the placement of the cannula tips.
Behavioral measures and statistical analysis
The same behavioral measures and statistical analysis used in Experiment 
1 was used in Experiment 2.
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Results
Experiment 1
The data reported are from the nine rats that maintained stable 
performance levels between drug administration sessions. The effects of 
dicyclomine were analyzed separately for each task manipulation.
Standard task
A repeated-measures dose x signal duration ANOVA on the relative 
number of hits for the three signal durations on the standard task found a 
significant main effect for signal duration (F(2, 16) = 142.74,/? < .001). Rats 
exhibited signal duration-dependent accuracy, with the hit rate higher following 
longer signal durations. A main effect of dose was also observed with a decrease 
in hits associated with an increase in the drug dose, (F(4,32) = 3.49, p  = .018) 
(Figure 1). A paired samples t test revealed a significant difference between 
vehicle and the highest drug dose (5.0 mg/kg dicyclomine) (t(8) = 2.52,/? = .036). 
A repeated-measures ANOVA for the relative number of correct rejections 
(Figure 2) or for omissions (Figure 3) found no significant main effects for dose.
Distracter task
A repeated-measures ANOVA found a significant main effect for signal 
duration on the relative number of hits (F(2,16) = 130.45,/? < .001), with a higher 
degree of accuracy following the longest signal duration (Figure 4). No main 
effect of drug dose or signal duration x drug dose interaction was observed. 
However, when the drug doses were averaged together and compared to vehicle a
20
main effect o f drug was observed (F(l ,8) = 7.51, p  = .025) as well as a dose x 
signal duration interaction (F(2,16) = 146.08,/? — .034). A t test was performed at 
each signal duration comparing vehicle to the average of the drug doses. O f those, 
the 500 ms signal was the only signal duration to show a significant difference 
(/(8) = 6.96,/? < .001). Further t tests at the 500 ms signal duration revealed 
significant differences in hits when vehicle was compared to 0.625 mg/kg 
dicyclomine (7(8) = 4.01,p  = .004), 2.5 mg/kg dicyclomine (/(8) = 5.93,p  < .001), 
and 5.0 mg/kg dicylomine (^(8) =2.94,p  = .019), but not 1.25 mg/kg dicylomine 
(/(8) = 2.159 , /? > .05). A repeated-measures ANOVA found no significant main 
effects for dose for the relative number of correct rejections (Figure 5) or for 
omissions (Figure 6).
Short ITI
A repeated-measures ANOVA found a significant main effect for signal 
duration on the relative number of hits for the three signal durations (F(2,16) = 
147.42,/? < .001), with the hit rate higher following the longest signal duration.
For hits a significant interaction was found between drug dose and signal duration, 
(F(8,64) = 3.05, p  = .006) (Figure 7). A one-way ANOVA was performed at each 
signal duration comparing drug dose. O f those, the 100 ms signal was the only 
signal duration to show significant differences between the drug doses (F(4,32) = 
3.83,/? = .016). A paired-samples t test revealed that hits were significantly 
reduced following the 5.0 mg/kg dose when compared to vehicle (t(8) = 2.929, p
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= .019). No significant main effects for dose were found for the relative number 
of correct rejections (Figure 8) or for omissions (Figure 9).
Experiment 2
The data reported here are from the ten rats that maintained stable 
performance levels between drug administration sessions and had correct cannula 
placement. A repeated-measures dose x signal duration ANOVA on the relative 
number of hits for the three signal durations on the standard task found a 
significant main effect for signal duration (F(2,18) = 99.9, p  = .001). Rats 
exhibited signal duration-dependent accuracy, with the hit rate higher following 
longer signal durations. For hits, a significant interaction was found for signal 
duration and dose (F(6,54) = 4.766, p  = .001) (Figure 10). A one-way ANOVA 
was performed at each signal duration comparing drug doses. The 500 ms signal 
was the only signal duration to show significant differences between the drug 
doses (F(3,27) = 5.485,/? = .006). A paired samples t-test compared the vehicle 
dose with each drug dose at the 500 ms signal. The highest drug dose (60 pg 
pirenzepine) significantly impaired performance when compared to vehicle (t(9) = 
2.944, p = .016). No other significant effects were found for the hits. A repeated- 
measures ANOVA for the relative number of correct rejections (Figure 11) or for 
omissions (Figure 12) found no significant main effects for dose as a factor.
Discussion
The current experiments investigated the effects o f Ml receptor blockade 
on performance in an attention demanding visual discrimination task. Animals 
were given M l receptor antagonists prior to performing a sustained attention task
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that required the discrimination of a brief visual signal from a nonsignal. 
Experiment 1 examined the effects of systemic administration of dicyclomine on 
three task manipulations designed to vary the amount o f attentional demands 
needed to complete the task. In the standard task, accuracy on the signal trials 
was decreased following the highest dose of dicyclomine. In the distracter task, at 
the 500 ms signal duration, signal detection was disrupted following multiple 
dicyclomine doses (0.625 mg/kg, 2.5 mg/kg, 5.0 mg/kg) compared to vehicle. 
Under these conditions, the effects of 1.25 mg/kg dose of dicyclomine approached 
statistical significance compared with vehicle. Finally, in the short ITI task 
decreased signal detection was observed at the 100 ms signal duration at the 
highest doses of dicyclomine. In Experiment 2, icv administration of the Ml 
receptor antagonist pirenzepine decreased signal detection at the longest signal 
duration (500 ms) at the highest dose (60 pg) when compared to vehicle.
In both experiments, no drug-induced deficits were found on accuracy 
during the nonsignal trials as the number of correct rejections did not change 
across dose. The ability to correctly reject nonsignals has been used previously in 
attention tasks as an indicator that the subjects displayed no lever bias and were 
continuing to respond based on the task rules (McGaughy et al., 1996). The 
decrease in the number o f hits was not caused by a side bias because an increase 
in the number o f relative correct rejections would have been expected if rats were 
only pressing the miss/correct rejection lever. No severe motor deficits or effects
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on motivation for reward were caused by the drugs, as evidenced by the lack of 
any significant drug-induced change in omissions.
In the standard task, systemic injection of the highest dose of dicyclomine 
created a decrease in signal detection at all signal durations. Severe disruption of 
visual processing seems unlikely to explain these deficits in signal detection 
because accuracy remained signal duration dependent under all drug 
administration conditions. The impairment in signal detection at all signal 
durations following systemic M l receptor blockade was expected and is 
consistent with the effects o f systemic muscarinic receptor blockade (Johnson & 
Burk, 2006; McQuail & Burk, 2006). A separate group of animals received an 
M l receptor antagonist into the lateral ventricle to test whether the effects of 
systemic M l receptor blockade were mediated centrally. Intraventricular 
infusions of an M l receptor antagonist produced similar, but not identical, 
disruptions in signal detection compared to systemic administration. Specifically, 
icv drug administration produced an accuracy that was only detected following 
the 500 ms signal. The disruption of performance at the 500 ms signal duration 
after icv administration of pirenzepine is similar to less extensive cortical 
cholinergic deafferentation created by intracortical infusions of 192 IgG-saporin, 
which produced loss of only 40 to 60 percent of cholinergic fibers in the anterior 
two-thirds of the cortex (McGaughy & Sarter, 1998). Similar to McGaughy and 
Sarter (1998) pirenzepine administration may have only produced a moderate 
impairment of the cholinergic system, resulting in the pattern o f detection deficits
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only at the longest signal duration. Icv administration of pirenzepine may have 
only produced a moderate impairment because the drug may not have diffused 
completely throughout the brain. An increase in the pirenzepine dose may have 
produced more substantial deficits in the detection of signals and provided a 
clearer idea of the effects of the drug manipulation.
In the short ITI task signal detection was disrupted at the 100 ms signal 
duration at the highest dose of pirenzepine. The lack of effect at the 25 ms signal 
duration may be due to a floor effect. Furthermore, the hit rate following the 25 
ms signal was relatively low in both experiments indicating that rats most 
commonly responded as if  no signal was presented on these trials. This relatively 
low hit rate may have contributed to difficulty observing further drug-induced 
declines in accuracy following the 25 ms signal.
In the distracter task, signal detection was disrupted at the 500 ms signal 
duration. Additionally, performance was disrupted at low doses of dicyclomine 
administration, while in the standard and short ITI tasks signal detection was only 
disrupted at the higher doses (see Figure 13 for a summary o f the effects of 
pirenzepine on the standard and distracter task). The distracter task is more taxing 
on the attentional system because the flashing houselight disrupts the animal’s 
ability to discriminate between signals and nonsignals. This increase in 
attentional demand may recruit different brain regions for performance which 
explains why performance was disrupted at lower doses of dicyclomine. Distinct 
subregions in the cortex are implicated depending on the attentional demands
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(Dailey, Cardinal, Robbins, 2004). One subregion, the prefrontal cortex, is 
important for maintenance of attention in the presence of distraction (Newman & 
McGaughy, 2008). Cholinergic lesions of the prefrontal cortex increased 
susceptibility to irrelevant stimuli during attention task performance (Newman & 
McGaughy, 2008). Other studies have shown that prefrontal cholinergic inputs 
contribute to distracter-related processing in animals performing a sustained 
attention task (Gill et al., 2000). Gill et al. (2000) demonstrated that increasing 
attentional demand by presenting a visual distracter increased prefrontal cortical 
neuronal firing rates. Removal of cholinergic projections to the medial prefrontal 
cortex decreased the firing rate of prefrontal cortical neurons and attenuated the 
frequency and amplitude of increased neuronal firing rates that were associated 
with the response of a distracter. In other words, the correlation between 
prefrontal cortical neuron firing rates and attentional demand is dependent on the 
integrity o f cholinergic inputs to the prefrontal cortex (Gill et al., 2000).
Moreover, blockade of prefrontal cortical muscarinic receptors was found to 
disrupt performance in the five choice serial reaction time task (Chudasama et al., 
2004). Infusions of scopolamine, into the prefrontal cortex produced deficits 
similar to those produced by basal forebrain cholinergic lesions. These findings, 
along with the present data, suggest that muscarinic receptors within the 
prefrontal cortex may be critical for mediating attentional performance, 
particularly when irrelevant stimuli are presented.
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The above studies all illustrate the importance of ACh in the prefrontal 
cortex under increased attentional demands. The present data offer some 
indication that the M l receptors in the prefrontal cortex may be sensitive to low 
doses o f dicyclomine. If  these receptors are inhibited at low doses of dicyclomine, 
higher doses will not be able to inhibit the receptors further and similar deficits 
will be found at both high and low doses of the drug. The available literature 
suggests that there are regional and layer-specific differences in M l and M2 
receptors in the cerebral cortex, although exactly how these differences may 
contribute to altered sensitivity to M l receptor antagonists remains unclear 
(Lidow, Gallager, Rakic, & Goldman-Rakic, 1989). In the standard task, a higher 
drug dose was needed to disrupt performance which suggests that prefrontal 
cortical M l receptors may not be as critical for performance of the standard 
version of this attention task. Previous research shows excitotoxic prefrontal 
cortical lesions, which destroy a variety o f inputs to this region, disrupt decisional 
processes necessary to complete the task (Miner, Ostrander, & Sarter, 1997). 
However, prefrontal ACh is not needed for performance on the standard task 
(Newman & McGaughy, 2008). Thus, dicyclomine may be affecting Ml 
receptors in other brain regions in the standard task. Similarly, the short ITI task 
performance was only disrupted at high doses of dicyclomine. The short ITI task 
may not be as attentionally demanding as the distracter task, which is supported 
by McGaughy & Sarter (1995) who found a high event rate did not disrupt
performance as greatly as a flashing houselight. Prefrontal cortical acetylcholine 
is most likely not being recruited to perform the task with a shorter ITI.
It is thought that in the presence of a distracter, top-down processing is 
required to sustain attention and filter out background “noise” (Sarter, Givens, 
Bruno, 2001). Top-down processing refers to knowledge driven mechanisms 
designed to enhance the processing of relevant sensory input to facilitate 
discrimination between targets and distracters (Kastner & Ungerleider, 2000).
The basal forebrain cholinergic system is proposed to contribute to the 
functionally top-down processes in sustained attention (Sarter et al., 2001). 
According to present hypotheses, when a visual distracter is introduced during 
task performance, the basal forebrain cholinergic system becomes activated in 
proportion to the level of attention required to maintain performance. When the 
basal forebrain is activated, under conditions of high attentional demand, a subset 
o f neurons in the medial prefrontal cortex detect this change and elevate their 
activity and subsequently project this enhanced activity to the posterior cortical 
regions to modulate the processing of signals (Nelson, Sarter, & Bruno, 2005). 
This hypothesis is supported by lesion studies that have found bilateral infusions 
of 192 IgG-saporin into the medial prefrontal cortex resulted in selective 
impairments in sustained attention (Newman & McGaughy, 2008). Signal 
detection accuracy was disrupted during the presence of a visual distracter, but 
not under standard attentional conditions. The lack of effect of bilateral medial 
prefrontal cortex cholinergic lesions on performance under standard attentional
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conditions suggests that medial prefrontal cortex cholinergic inputs may have less 
of a role in enhancing signal detection and more of a role in filtering out irrelevant 
stimuli. Loss of cholinergic inputs to the posterior parietal cortex increases 
response latencies, but does not affect accuracy, when the irrelevant flashing 
houselight is presented in the present attention task (Broussard, Karelina, Sarter,
& Givens, 2009). Thus, it seems unlikely that the effects of M l receptor 
antagonists in the present experiment, which decrease signal detection accuracy, 
are mediated within the posterior parietal cortex.
The present experiment is consistent with previous studies that have found 
cognitive deficits following M l receptor blockade. Disruptions in memory 
performance have been reported after administration of an M l receptor antagonist 
(Bymaster et al., 1993; Aura et al., 1997; Anagnostaras et al., 2003), but the effect 
on attention has not been studied. The present experiment found that blocking 
M l receptors decreases accuracy in an attention demanding task and further 
disrupts performance when attentional demands are increased. The disruption in 
memory performance found in previous studies may be due to a disruption in 
attentional capacity caused by blocking the M l receptor.
These results further support the role of the M l receptor in AD. 
Improvements in cognition have been reported following the use of muscarinic 
M l receptor agonists (Clader & Wang, 2005) while an impairment of M l 
mediated signaling may underlie the cognitive decline associated with the disease 
(Tsang et al., 2007). However, Tsang et al. (2007) found that M l/G  protein
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decoupling was correlated with reductions in PKC activity and NMDA receptor 
density. They suggest postsynaptic cholinergic dysfunction may underlie the 
cognitive features of AD. In addition, these data suggest that M l receptor 
agonists may be beneficial during the early stages of AD, while M l/G  protein 
coupling is unaffected.
The current study was limited by the fact that dicyclomine was 
administered systemically, so the drug could have had peripheral effects. In 
addition, pirenzepine was administered into the lateral right or left ventricle so it 
affected all brain regions, not just regions specialized for attention. It may be 
beneficial to investigate the effects o f M l receptor blockade on specific areas in 
the brain, such as the prefrontal cortex. Future studies could also investigate if 
M l receptor agonists could attenuate the attentional impairments caused by 
moderate impairment of the cholinergic system.
In summary, M l receptor blockade decreased signal detection accuracy in 
an attention task. Deficits in attention were observed following systemic 
administration of dicyclomine. Additionally, when attentional demands were 
increased deficits in signal detection were observed at lower doses of pirenzepine 
that did not affect performance in the standard task. Signal detection was also 
disrupted following icv administration o f pirenzepine. The effects of 
acetylcholine on attention seem to be mediated, in part, by the M l receptor. The 
present data offer a starting point to understanding the effect of the M l receptor 
on attention.
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Figure Captions
Figure 1. Relative hits across dicyclomine doses at each signal duration in the 
standard task. Relative hits were significantly decreased following the 5.0 mg/kg 
dicyclomine dose.
Figure 2. Relative correct rejections across dicyclomine doses in the standard task. 
Correct rejections were not significantly affected by dicyclomine administration 
at any dose.
Figure 3. The number of omissions across drug doses in the standard task. 
Omissions were not significantly affected by dicyclomine administration at any 
dose.
Figure 4. Relative hits across dicyclomine doses at each signal duration in the 
distracter task. Relative hits were significantly decreased at the 500 ms signal 
duration following the 0.625, 2.5, and 5.0 mg/kg dicyclomine doses and 
approaching significance at the 1.25 mg/kg dose. No other significant effects were 
observed at the 25 and 100 ms signal duration.
Figure 5. Relative correct rejections across dicyclomine doses in the distracter 
task. Correct rejections were not significantly affected by dicyclomine 
administration at any dose.
Figure 6. The number of omissions across drug doses in the distracter task. 
Omissions were not significantly affected by dicyclomine administration at any 
dose.
Figure 7. Relative hits across dicyclomine doses at each signal duration in the 
short ITI task. Relative hits were significantly decreased at the 100 ms signal
40
duration following the 5.0 mg/kg dicyclomine dose. No other significant effects 
were observed at the 25 and 500 ms signal duration.
Figure 8. Relative correct rejections across dicyclomine doses in the short ITI 
task. Correct rejections were not significantly affected by dicyclomine 
administration at any dose.
Figure 9. The number of omissions across drug doses in the short ITI task. 
Omissions were not significantly affected by dicyclomine administration at any 
dose.
Figure 10. Relative number of hits across pirenzepine doses at each signal 
duration in the standard task. Relative hits were significantly decreased at the 500 
ms signal duration following the 60 pg pirenzepine dose. No other significant 
effects were observed at the 25 and 100 ms signal duration.
Figure 11. Relative correct rejections across dicyclomine doses in the standard 
task. Correct rejections were not significantly affected by dicyclomine 
administration at any dose.
Figure 12. The number o f omissions across drug doses in the standard task. 
Omissions were not significantly affected by pirenzepine administration at any 
dose.
Figure 13. Relative hits were averaged across the various signal durations for 
each dicyclomine dose in the standard and distracter task (Experiment 1). In the 
standard task, relative hits decreased at the highest dicyclomine dose (5.0 mg/kg)
41
while in the distracter task relative hits decreased across most doses (0.625, 2.5,
5.0 mg/kg).
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